Clinical Trial Update: Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine [Phase 1, Phase 2]

View source ↗

Summary

This entry notes a Phase I/II clinical trial evaluating a reduced-dose Diphtheria-Tetanus-Pertussis vaccine; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine (Diphtheria, Tetanus, and Pertussis vaccine, acellular, reduced dose)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: Tetanus, Diphtheria and Acellular Pertussis Vaccination, Tetanus | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING